Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Mylan Laboratories et al.
Current Parent Company: Viatris
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Recap of Ownership Changes:  subscribe to see this data field
Penalty: $108,000,000
Year: 2000
Date: November 29, 2000
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Mega-Scandal: Drug Pricing Abuses
Violation Description: Mylan paid $100 million (plus $8 million in legal fees) to settle a price-fixing case alleging that it developed a plan to drastically increase prices on two of its generic drugs by cutting off its competitors' supply of the drugs' active ingredients. Mylan accomplished this by entering into long-term profit-sharing agreements with industry suppliers and distributors that gave Mylan the only reliable sources of the active ingredients. The three other defendants -- which apparently were not required to share in the settlement costs -- were New Jersey-based Cambrex Corporation, Italian pharmaceutical ingredient manufacturer Profarmaco S.r.l. (a subsidiary of Cambrex), and New York-based drug distributor Gyma. The settlement was also announced by the Federal Trade Commission (see separate entry).
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Court: District of the District of Columbia
Civil or Criminal Case: civil
Case ID: 1:98-cv-3115
Case Name: Connecticut v. Mylan Laboratories, Inc. (In re Lorazepam & Clorazepate Antitrust Litigation)
HQ Country of Current Parent: USA
HQ State of Current Parent: Pennsylvania
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Link to PACER Case Docket (must be logged in): (click here)
Link to Archived Court Document:  subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.